Drug Trials Snapshots: EXBLIFEP

EXBLIFEP is a combination of cefepime and enmetazobactam that is indicated for the treatment of patients 18 years and older with complicated urinary tract infections (cUTI), including pyelonephritis, caused by designated susceptible microorganisms.